Association of Ingrown Toenails With Flat Foot, Hallux Abducto Valgus and Hallux Limitus

February 16, 2019 updated by: Him Shun KEI, Chinese University of Hong Kong

This study will have implications for any healthcare professionals who routinely manage ingrown toenails. Although different conservative and surgical treatment have been suggested, the recurrent rate is still high ranging from 20% to 30%. The objective of this study was to investigate the association of ingrown toenail (IGTN) with flat foot, hallux abducto valgus (HAV) and hallux limitus (HL), and to provide directions for addressing biomechanical risk factors in the prevention of recurrent ingrown toenails. This was the first study to investigate the association of IGTN with flat foot, and the first study in Chinese community to investigate the association of IGTN with HAV or HL.

Participants with ingrown toenails (IGTN) were recruited to this study and compared with control participants with no history of ingrown toenails.

The inclusion criteria for the IGTN group were: (1) history of ingrown toenails on hallux within 1 year and (2) dorso-plantar standing view of foot x-ray taken or to be taken.

The exclusion criteria for the IGTN group were: (1) paediatrics (Age<18), (2) pincer nails / fungal nails, (3) prior existence of osteoarticular surgery in the foot, (4) severe trauma that changes foot morphology, (5) uncontrolled systemic disease, (6) pre-existing neurological diseases and (7) lower limb paralysis or paresis.

The inclusion criterion for the control group was dorso-plantar standing view of foot x-ray taken or to be taken.

The exclusion criteria for the control group were: (1) all the exclusion criteria of IGTN group, (2) history of IGTN in his or her lifetime and (3) flatfoot / first metatarsophalangeal joint pathology as the chief complaint.

The symptomatic foot (or the more symptomatic foot in the case of bilateral involvement) in the IGTN group was examined. The left or right foot of the control group was randomly selected such that the ratio of the left or the right foot in the IGTN and control group was the same.

Their foot posture index-6 components, Staheli's index, radiological hallux valgus angle and active maximum dorsiflexion of the first metatarsophalangeal joint on weight-bearing were measured and compared.

For dependent variables with significant correlation, a one-way multivariate analysis of variance (MANOVA) was carried out to determine if there was a significant difference on the combined dependent variables. For dependent variables without significant correlation, separate independent sample t-tests / welch t-tests were performed.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Precautions were taken to ensure consistency in measurement. To standardize the bisection techniques in measuring radiological hallux valgus angle, this study followed the recommendation from the American Orthopaedic Foot & Ankle Society. The longitudinal axis of the first metatarsal and that of the first proximal phalanx were formed respectively by 2 reference points marked on each of the two bones. The reference points on the first proximal phalanx were 1/2 to 1 cm proximal or distal to the articular surface while the reference points on the first metatarsal were 1 to 2 cm proximal or distal to the articular surface.

The active maximum dorsiflexion of the first metatarsophalangeal joint was measured with goniometer on weight-bearing. The bisection was carried out under a weight-bearing condition to avoid error due to soft-tissue movement when participants changed from a non weight-bearing position to a weight-bearing position.

Study Type

Observational

Enrollment (Actual)

41

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, Hong Kong
        • Prince of Wales Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients attending the Orthopaedic out-patient clinic at Prince of Wales Hospital in Hong Kong

Description

Inclusion criteria for the IGTN group:

  • history of ingrown toenails on hallux within 1 year
  • dorso-plantar standing view of foot x-ray taken or to be taken

Exclusion criteria for the IGTN group:

  • paediatrics (Age<18)
  • pincer nails / fungal nails
  • prior existence of osteoarticular surgery in the foot
  • severe trauma that changes foot morphology
  • uncontrolled systemic disease
  • pre-existing neurological diseases
  • lower limb paralysis or paresis

Inclusion criterion for the control group:

- dorso-plantar standing view of foot x-ray taken or to be taken

Exclusion criteria for the control group:

  • all the exclusion criteria of IGTN group
  • history of IGTN in his or her lifetime
  • flatfoot / first metatarsophalangeal joint pathology as the chief complaint

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control
Ingrown toenails
No intervention will be performed. Only assessment will be done.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Foot Posture Index-6 components
Time Frame: throughout the study, within 1 year after ingrown toenails for the ingrown toenail group
  • Clinical assessment for flat foot
  • Normal: 0 to +5
  • Pronated: +5 to +9 ; Highly pronated: +10 or above
  • Supinated: -1 to -4; Highly supinated: -5 to -12
throughout the study, within 1 year after ingrown toenails for the ingrown toenail group
Staheli's Index
Time Frame: throughout the study, within 1 year after ingrown toenails for the ingrown toenail group
  • It provides a measurement of flat foot on footprint.
  • The Staheli's index increases as the foot becomes more pronated and is closer to zero as the foot becomes more supinated.
throughout the study, within 1 year after ingrown toenails for the ingrown toenail group
radiological Hallux Valgus Angle
Time Frame: throughout the study, within 1 year after ingrown toenails for the ingrown toenail group
  • Radiological measurement for hallux abducto valgus
  • Normal: <15º
throughout the study, within 1 year after ingrown toenails for the ingrown toenail group
Active maximum dorsiflexion of the first metatarsophalangeal joint on weight bearing
Time Frame: throughout the study, within 1 year after ingrown toenails for the ingrown toenail group
Clinical measurement with goniometer for hallux limitus
throughout the study, within 1 year after ingrown toenails for the ingrown toenail group

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 14, 2018

Primary Completion (ACTUAL)

April 27, 2018

Study Completion (ACTUAL)

April 27, 2018

Study Registration Dates

First Submitted

February 13, 2019

First Submitted That Met QC Criteria

February 14, 2019

First Posted (ACTUAL)

February 15, 2019

Study Record Updates

Last Update Posted (ACTUAL)

February 19, 2019

Last Update Submitted That Met QC Criteria

February 16, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hallux Limitus

Clinical Trials on No intervention

3
Subscribe